Exacerbation of acetaminophen hepatotoxicity by the anthelmentic drug fenbendazole

Toxicological Sciences

Volumn 125, Issue 2, 2012, Pages 607-612

  Gardner, Carol R ^a   Mishin, Vladimir ^a   Laskin, Jeffrey D ^b   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Acetaminophen; Cytochrome P450; Fenbendazole; Glutathione; Liver

Indexed keywords

AMINOTRANSFERASE; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; FENBENDAZOLE; GLUTATHIONE; PARACETAMOL; PARACETAMOL GLUCURONIDE; PHOSPHATE BUFFERED SALINE;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIVER; LIVER NECROSIS; LIVER TOXICITY; MALE; MORTALITY; MOUSE; NONHUMAN;

MUS; RODENTIA;

EID: 84856094261     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr301     Document Type: Article

References (48)

1. Agersborg, S. S., Garza, K. M., and Tung, K. S. (2001). Intestinal parasitism terminates self tolerance and enhances neonatal induction of autoimmune disease and memory. Eur. J. Immunol. 31, 851-859.
2. Bower, W. A., Johns, M., Margolis, H. S., Williams, I. T., and Bell, B. P. (2007). Population-based surveillance for acute liver failure. Am. J. Gastroenterol. 102, 2459-2463.
3. Brunner, L. J., and Bai, S. (1999). Simple and rapid assay for acetaminophen and conjugated metabolites in low-volume serum samples. J. Chromatogr. B Biomed. Sci. Appl. 732, 323-329.
4. Bugarski, D., Jovcić, G., Katić-Radivojević, S., Petakov, M., Krstić, A., Stojanović, N., and Milenković, P. (2006). Hematopoietic changes and altered reactivity to IL-17 in Syphacia obvelata-infected mice. Parasitol. Int. 55, 91-97.
5. Capece, B. P., Virkel, G. L., and Lanusse, C. E. (2009). Enantiomeric behaviour of albendazole and fenbendazole sulfoxides in domestic animals: Pharmacological implications. Vet. J. 181, 241-250.
6. Chang, T. K., Crespi, C. L., and Waxman, D. J. (2006). Spectrophotometric analysis of human CYP2E1-catalyzed p-nitrophenol hydroxylation. Methods Mol. Biol. 320, 127-131.
7. Chiu, H., Gardner, C. R., Dambach, D. M., Brittingham, J. A., Durham, S. K., Laskin, J. D., and Laskin, D. L. (2003). Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G959-G966.
8. Coghlan, L. G., Lee, D. R., Psencik, B., and Weiss, D. (1993). Practical and effective eradication of pinworms (Syphacia muris) in rats by use of fenbendazole. Lab. Anim. Sci. 43, 481-487.
9. Cohen, S. D., Pumford, N. R., Khairallah, E. A., Boekelheide, K., Pohl, L. R., Amouzadeh, H. R., and Hinson, J. A. (1997). Selective protein covalent binding and target organ toxicity. Toxicol. Appl. Pharmacol. 143, 1-12.
10. Cooper, K. O., Reik, L. M., Jayyosi, Z., Bandiera, S., Kelley, M., Ryan, D. E., Daniel, R., McCluskey, S. A., Levin, W., and Thomas, P. E. (1993). Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch. Biochem. Biophys. 301, 345-354.
11. Dalvi, R. R., Gawai, K. R., and Dalvi, P. S. (1991). Lack of in vitro and in vitro effects of fenbendazole on phase I and phase II biotransformation enzymes in rats, mice and chickens. Vet. Hum. Toxicol. 33, 548-551.
12. Dawson, P. J., Gutteridge, W. E., and Gull, K. (1984). A comparison of the interaction of anthelmintic benzimidazoles with tubulin isolated from mammalian tissue and the parasitic nematode Ascaridia galli. Biochem. Pharmacol. 33, 1069-1074.
13. Dewa, Y., Nishimura, J., Muguruma, M., Matsumoto, S., Takahashi, M., Jin, M., and Mitsumori, K. (2007). Gene expression analyses of the liver in rats treated with oxfendazole. Arch. Toxicol. 81, 647-654.
14. Gardner, C. R., Gray, J. P., Joseph, L. B., Cervelli, J., Bremer, N., Kim, Y., Mishin, V., Laskin, J. D., and Laskin, D. L. (2010). Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 245, 36-46.
15. Gleizes, C., Eeckhoutte, C., Pineau, T., Alvinerie, M., and Galtier, P. (1991). Inducing effect of oxfendazole on cytochrome P450IA2 in rabbit liver. Consequences on cytochrome P450 dependent monooxygenases. Biochem. Pharmacol. 41, 1813-1820.
16. Gregus, Z., Madhu, C., and Klaassen, C. D. (1988). Species variation in toxication and detoxication of acetaminophen in vivo: A comparative study of biliary and urinary excretion of acetaminophen metabolites. J. Pharmacol. Exp. Ther. 244, 91-99.
17. Hunter, R. L., Choi, D. Y., Kincer, J. F., Cass, W. A., Bing, G., and Gash, D. M. (2007). Fenbendazole treatment may influence lipopolysaccharide effects in rat brain. Comp. Med. 57, 487-492.
18. Jaeschke, H. (1990). Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: The protective effect of allopurinol. J. Pharmacol. Exp. Ther. 255, 935-941.
19. Koop, D. R. (1986). Hydroxylation of p-nitrophenol by rabbit ethanolinducible cytochrome P- 450 isozyme 3a. Mol. Pharmacol. 29, 399-404.
20. Laine, J. E., Auriola, S., Pasanen, M., and Juvonen, R. O. (2009). Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes. Xenobiotica 39, 11-21.
21. Manimaran, A., Sarkar, S. N., and Sankar, P. (2010). Influence of repeated preexposure to arsenic on acetaminophen-induced oxidative stress in liver of male rats. Food Chem. Toxicol. 48, 605-610.
22. Masubuchi, Y., Nakayama, J., and Watanabe, Y. (2011). Sex difference in susceptibility to acetaminophen hepatotoxicity is reversed by buthionine sulfoximine. Toxicology 287, 54-60.
23. McNair, D. M., and Timmons, E. H. (1977). Effects of Aspiculuris tetraptera and Syphacia obvelata on exploratory behavior of an inbred mouse strain. Lab. Anim. Sci. 27, 38-42.
24. Michels, C., Goyal, P., Nieuwenhuizen, N., and Brombacher, F. (2006). Infection with Syphacia obvelata (pinworm) induces protective Th2 immune responses and influences ovalbumin-induced allergic reactions. Infect. Immun. 74, 5926-5932.
25. Miners, J. O., Drew, R., and Birkett, D. J. (1984). Mechanism of action of paracetamol protective agents in mice in vivo. Biochem. Pharmacol. 33, 2995-3000.
26. Moyer, A. M., Fridley, B. L., Jenkins, G. D., Batzler, A. J., Pelleymounter, L. L., Kalari, K. R., Ji, Y., Chai, Y., Nordgren, K. K., and Weinshilboum, R. M. (2011). Acetaminophen-NAPQI hepatotoxicity: A cell line model system genome-wide association study. Toxicol. Sci. 120, 33-41.
27. Murray, M., Hudson, A. M., and Yassa, V. (1992). Hepatic microsomal metabolism of the anthelmintic benzimidazole fenbendazole: Enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug. Chem. Res. Toxicol. 5, 60-66.
28. Nakae, D., Oakes, J. W., and Farber, J. L. (1988). Potentiation in the intact rat of the hepatotoxicity of acetaminophen by 1,3-bis(2-chloroethyl)-1-nitrosourea. Arch. Biochem. Biophys. 267, 651-659.
29. Omiecinski,C. J.,Remmel,R.P., andHosagrahara,V. P. (1999).Concise reviewof the cytochrome P450s and their roles in toxicology. Toxicol. Sci. 48, 151-156.
30. Ramachandran, R., and Kakar, S. (2009). Histological patterns in drug-induced liver disease. J. Clin. Pathol. 62, 481-492.
31. Ramp, A. A., Hall, C., and Orian, J. M. (2010). Strain-related effects of fenbendazole treatment on murine experimental autoimmune encephalomyelitis. Lab. Anim. 44, 271-273.
32. Savlík, M., Fimanová, K., Szotáková, B., Lamka, J., and Skálová, L. (2006). Modulation of porcine biotransformation enzymes by anthelmintic therapy with fenbendazole and flubendazole. Res. Vet. Sci. 80, 267-274.
33. Schuphan, I., Segall, Y., Rosen, J. D., and Casida, J. E. (1981). Toxicological significance of oxidation and rearrangement of S-chloroallyl thio- and dithiocarbamate herbicides. In Sulfur in Pesticide Action and Metabolism. (J. D. Rosen, P. S. Magee, and J. E. Casida, Eds.), pp. 65-82. American Chemical Society, Washington, DC.
34. Shoda, T., Onodera, H., Takeda, M., Uneyama, C., Imazawa, T., Takegawa, K., Yasuhara, K., Watanabe, T., Hirose, M., and Mitsumori, K. (1999). Liver tumor promoting effects of fenbendazole in rats. Toxicol. Pathol. 27, 553-562.
35. Short, C. R., Barker, S. A., and Flory, W. (1988). Comparative drug metabolism and disposition in minor species. Vet. Hum. Toxicol. 30(Suppl. 1), 2-8.
36. Snawder, J. E., Roe, A. L., Benson, R. W., and Roberts, D. W. (1994). Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: Relation to toxicity. Biochem. Biophys. Res. Commun. 203, 532-539.
37. Stresser, D. M., Blanchard, A. P., Turner, S. D., Erve, J. C., Dandeneau, A. A., Miller, V. P., and Crespi, C. L. (2000). Substrate-dependent modulation of CYP3A4 catalytic activity: Analysis of 27 test compounds with four fluorometric substrates. Drug Metab. Dispos. 28, 1440-1448.
38. Tonge, R. P., Kelly, E. J., Bruschi, S. A., Kalhorn, T., Eaton, D. L., Nebert, D. W., and Nelson, S. D. (1998). Role of CYP1A2 in the hepatotoxicity of acetaminophen: Investigations using Cyp1a2 null mice. Toxicol. Appl. Pharmacol. 153, 102-108.
39. Ueng, Y. F., Jan, W. C., Lin, L. C., Chen, T. L., Guengerich, F. P., and Chen, C. F. (2002). The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. Drug Metab. Dispos. 30, 349-353.
40. van Beusekom, C. D., Schipper, L., and Fink-Gremmels, J. (2010). Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs. J. Vet. Pharmacol. Ther. 33, 519-527.
41. Velík, J., Baliharová, V., Fink-Gremmels, J., Bull, S., Lamka, J., and Skálová, L. (2004). Benzimidazole drugs and modulation of biotransformation enzymes. Res. Vet. Sci. 76, 95-108.
42. Villar, D., Cray, C., Zaias, J., and Altman, N. H. (2007). Biologic effects of fenbendazole in rats and mice: A review. J. Am. Assoc. Lab. Anim. Sci. 46, 8-15.
43. Wagner, M. (1988). The effect of infection with the pinworm (Syphacia muris) on rat growth. Lab. Anim. Sci. 38, 476-478.
44. Walker, R. M., Massey, T. E., McElligott, T. F., and Racz, W. J. (1982). Acetaminophen toxicity in fed and fasted mice. Can. J. Physiol. Pharmacol. 60, 399-404.
45. Watanabe, T., Sagisaka, H., Arakawa, S., Shibaya, Y., Watanabe, M., Igarashi, I., Tanaka, K., Totsuka, S., Takasaki, W., and Manabe, S. (2003). A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S, R)-sulfoximine. J. Toxicol. Sci. 28, 455-469.
46. -/- and wild-type mice. Drug Metab. Dispos. 32, 681-684.
47. Yoon, M. Y., Kim, S. J., Lee, B. H., Chung, J. H., and Kim, Y. C. (2006). Effects of dimethylsulfoxide on metabolism and toxicity of acetaminophen in mice. Biol. Pharm. Bull. 29, 1618-1624.
48. Yuan, L., and Kaplowitz, N. (2009). Glutathione in liver diseases and hepatotoxicity. Mol. Aspects Med. 30, 29-41.